Seite - (000201) - in Biomedical Chemistry: Current Trends and Developments

Hsu, C. Y. (1998). Ischemic Stroke: From Basic Mechanisms to New Drug Development, Karger. Ikeda, Y., K. A. Dick, et al. (2006). Spectrin mutations cause spinocerebellar ataxia type 5. Nature Genetics, 38(2), 184-190. Iuculano, T. and R. Cohen Kadosh (2013). The mental cost of cognitive enhancement. The Journal of neuroscience: the official journal of the Society for Neuroscience, 33(10), 4482-4486. Iuculano, T. and R. Cohen Kadosh (2014). Preliminary evidence for performance enhancement following parietal lobe stimulation in Developmental Dyscalculia. Frontier Human Neuroscience, 8, 38. Kalivas, P. W. and P. Duffy (1997). “Dopamine regulation of extracellular glutamate in the nucleus accumbens.” Brain research 761(1): 173-177. Kamenetz, F., T. Tomita, et al. (2003). APP processing and synaptic function. Neuron, 37(6), 925- 937. Katsura, K., T. Kristian, et al. (1994). Energy metabolism, ion homeostasis, and cell damage in the brain. Biochemistry Soic Trans, 22(4), 991-996. Kew, J. N. and J. A. Kemp (2005). Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl), 179(1), 4-29. Kim, C. H., J. Lee, et al. (2008). Metabotropic glutamate receptors: phosphorylation and receptor signaling. Journal of Neurosci Research, 86(1), 1-10. Kim, J. H., R. Anwyl, et al. (2001). Use-dependent effects of amyloidogenic fragments of (beta)- amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. The Journal of Neuroscience, 21(4), 1327-1333. Kish, S. J., J. Tong, et al. (2008). Preferential loss of serotonin markers in caudate versus putamen in Parkinson’s disease. Brain, 131(Pt 1), 120-131. Koob, G. F. (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences, 13(5), 177-184. Koob, G. F. (2014). Neurocircuitry of alcohol addiction: synthesis from animal models. Handbook of Clinical Neurology, 125, 33-54. Koob, G. F. and N. R. Swerdlow (1988). S The functional output of the mesolimbic dopamine system. Annuals of the New York Academy of Science, 537, 216-227. Kroemer, G., L. Galluzzi, et al. (2009). Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death & Differentiation, 16(1), 3-11. Lawrie, S. M. and S. S. Abukmeil (1998). Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. The British Journal of Psychiatry, 172, 110-120. Lee, A. and D. V. Pow (2010). Astrocytes: Glutamate transport and alternate splicing of transporters. International Journal of Biochemical & Cellullar Biology, 42(12), 1901-1906. Lee, Y. S. and A. J. Silva (2009). The molecular and cellular biology of enhanced cognition. Nature Review. Neuroscience, 10(2), 126-140. Leisman, G., O. Braun-Benjamin, et al. (2014). Cognitive-motor interactions of the basal ganglia in development. Frontiers in Systems & Neuroscience, 8, 16. Lewis, D. A., T. Hashimoto, et al. (2005). Cortical inhibitory neurons and schizophrenia. Nature reviews. Neuroscience, 6(4), 312-324.